bupropion hydrochloride
Generic: bupropion hydrochloride
Labeler: preferred pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
bupropion hydrochloride
Generic Name
bupropion hydrochloride
Labeler
preferred pharmaceuticals inc.
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
bupropion hydrochloride 150 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68788-7786
Product ID
68788-7786_35ff52b6-09b7-4f6f-9248-5e49690212b3
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA210497
Listing Expiration
2026-12-31
Marketing Start
2020-10-21
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
687887786
Hyphenated Format
68788-7786
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bupropion hydrochloride (source: ndc)
Generic Name
bupropion hydrochloride (source: ndc)
Application Number
ANDA210497 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 150 mg/1
Packaging
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-1)
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-3)
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-6)
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-8)
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-9)
Packages (5)
68788-7786-1
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-1)
68788-7786-3
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-3)
68788-7786-6
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-6)
68788-7786-8
120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-8)
68788-7786-9
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-9)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "35ff52b6-09b7-4f6f-9248-5e49690212b3", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541"], "spl_set_id": ["42e228a2-25b3-44a6-8da7-6616ca44ac7f"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-1)", "package_ndc": "68788-7786-1", "marketing_start_date": "20201021"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-3)", "package_ndc": "68788-7786-3", "marketing_start_date": "20201021"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-6)", "package_ndc": "68788-7786-6", "marketing_start_date": "20201021"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-8)", "package_ndc": "68788-7786-8", "marketing_start_date": "20201021"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-7786-9)", "package_ndc": "68788-7786-9", "marketing_start_date": "20201021"}], "brand_name": "BUPROPION HYDROCHLORIDE", "product_id": "68788-7786_35ff52b6-09b7-4f6f-9248-5e49690212b3", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68788-7786", "generic_name": "BUPROPION HYDROCHLORIDE", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPROPION HYDROCHLORIDE", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA210497", "marketing_category": "ANDA", "marketing_start_date": "20201021", "listing_expiration_date": "20261231"}